UnitedHealth Group has become an industry leader. Can the company survive Obamacare?
A weekly adventure in giving unknown companies some attention.
A look back at the hidden health care stories from last week.
Could Walgreen's nonrenewal cripple this drug distributor?
A roundup of the day's best performers within the S&P 500 and what their moves mean for investors.
Market-trouncing returns could be written in this 5-Star.
Three earnings reports set the stage for an otherwise quiet week in the health-care sector.
Let's look forward to this company's next earnings report.
This is a rocket ride you want no part of.
The Fool looks at 3 horrendous health-care stocks from the past week.